Skip to main navigation Skip to search Skip to main content

How do we expand the lung donor pool?

Research output: Contribution to journal › Review Article › Research › peer-review

Abstract

Purpose of review. Lung transplantation activity continues to be limited by the availability of timely quality donor lungs. It is apparent though that progress has been made. The steady evolution of clinical practice, combined with painstaking scientific discovery and innovation are described. Recent findings. There have been successful studies reporting innovations in the wider use and broader consideration of donation after circulatory death donor lungs, including an increasing number of transplants from each of the controlled, uncontrolled and medically assisted dying donor descriptive categories. Donors beyond age 70 years are providing better than expected long-term outcomes. Hepatitis C PCR positive donor lungs can be safely used if treated postoperatively with appropriate antivirals. Donor lung perfusion at a constant 10 degrees appears capable of significantly improving donor logistics and ex-vivo lung perfusion offers the potential of an ever-increasing number of novel donor management roles. Bioartificial and xenografts remain distant possibilities only at present. Summary Donor lungs have proved to be surprisingly robust and combined with clinical, scientific and engineering innovations, the realizable lung donor pool is proving to be larger than previously thought.

Original languageEnglish
Pages (from-to)398-404
Number of pages7
JournalCurrent Opinion in Pulmonary Medicine
Volume30
Issue number4
DOIs
Publication statusPublished - Jul 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • donation after circulatory death
  • ex vivo lung perfusion
  • lung transplantation
  • organ donor management

Cite this